Microdosing psychedelics linked to lower anxiety, depression, stress… can it help?
An international study of more than 8,500 people from 84 countries shows a link between microdosing and reduced symptoms of depression, anxiety, and stress… [a recent study claimed “psilocybin” microdosing has no impact, however, the participants in that Amsterdam (Dutch)-based study did not consume psilocybin-containing mushrooms, but the species [sclerotia galindoi, hard nodules that grow underground]… this fact (about sclerotia galindoi) has been left out of reporting discussing the sclerotia galindoi microdosing study by BigThink, New Atlas, etc.]
A November 2021 study, by the University of British Columbia (UBC), observed that people who microdosed psychedelics, such as psilocybin and LSD, reported less anxiety, depression, and stress than non-microdosers. Research from 2018 suggests that microdosing may improve creativity and focus, which may have contributed to microdosing’s recent rise in popularity. Research from 2019 suggests that psilocybin (magic mushrooms)… are among the most commonly microdosed psychedelics. Evidence from 2019 suggests that low doses administered every few days could be considered safe. A January 2021 study posits a therapeutic value to psychedelic microdosing based on self-reports. A November 2021 study, by the University of British Columbia (UBC), observed that people who microdosed psychedelics, such as psilocybin and LSD, reported less anxiety, depression, and stress than non-microdosers…
Original Article: (NWI & Psychcentral & BigThink & New Atlas):
Microdosing psychedelics linked to lower anxiety, depression, stress & Microdosing lsd: can it help or harm mental health? & Microdosing psilocybin for anxiety and depression? A placebo may be just as good & No difference between psilocybin microdosing and placebo, trial finds
Artwork Fair Use: Public domain